Viewing Study NCT01550393


Ignite Creation Date: 2025-12-25 @ 1:12 AM
Ignite Modification Date: 2025-12-25 @ 11:23 PM
Study NCT ID: NCT01550393
Status: COMPLETED
Last Update Posted: 2016-07-11
First Post: 2012-03-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Biomarkers in Urine Samples From Patients With Wilms Tumor
Sponsor: Children's Oncology Group
Organization:

Study Overview

Official Title: Discovery and Validation of Wilms Tumor Markers Using Urine Proteomics
Status: COMPLETED
Status Verified Date: 2016-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE: Studying samples of urine from patients with cancer in the laboratory may help doctors identify biomarkers related to cancer.

PURPOSE: This clinical trial studies biomarkers in urine from patients with Wilms tumor.
Detailed Description: OBJECTIVES:

* To validate the prognostic performance of specific-candidate Wilms tumor markers by measuring their urinary concentration using enzyme-linked immunosorbent assays (ELISAs) in urine specimens collected at diagnosis from 50 patients with favorable histology Wilms tumor who relapsed and 50 patients who did not relapse.

OUTLINE: Urine specimens are analyzed using enzyme-linked immunosorbent assays (ELISAs) for biomarkers.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
COG-AREN12B4 OTHER Children's Oncology Group View
CDR0000727337 OTHER Clinical Trials.gov View
AREN12B4 OTHER Children's Oncology Group View
NCI-2012-00702 REGISTRY CTRP (Clinical Trial Reporting Program) View